TB-500 Research for Wound Healing
An evidence-based overview of research examining TB-500 in the context of wound healing. This page synthesizes findings from peer-reviewed literature.
Research Summary
Thymosin beta-4's wound healing effects are among its most studied properties. The peptide increases re-epithelialization by 42-61% in rat wound models (Malinda et al., 1999), promoting both keratinocyte and fibroblast migration. The mechanism involves actin sequestration, allowing cells to become more mobile and migrate to wound sites. Additional benefits include stimulation of collagen production and extracellular matrix formation. Phase 2 clinical trials for venous stasis ulcers showed approximately one month faster healing compared to placebo. These trials used the full thymosin beta-4 protein, not TB-500.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Wound Healing
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. TB-500 may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.